Abbott Laboratories
(NYSE: ABT)
-0.24
-0.65%
Abbott Laboratories, a large-cap growth company in the health care sector, is expected to significantly outperform the market over the next six months with less than average risk.
10 is the best possible rating.
The price-to-earnings multiple is lower than average for all stocks in the StockScouter universe. Positive
The StockScouter measure of relative price change and consistency is very high. Very positive
Earnings growth in the past year has accelerated rapidly compared to earnings growth in the past three years. Positive
ConShares are being heavily sold by financial institutions. Neutral for a large company like ABT
The most recent quarterly earnings report was approximately equal to or higher than analysts’ consensus forecast, but not to a degree that is predictive of future returns. Neutral
Earnings growth in the past year has accelerated rapidly compared to earnings growth in the past three years. Positive
One or more analysts has modestly increased quarterly earnings estimates for ABT. Positive
Insider trading information is unavailable or inconsistent.
Shares are being heavily sold by financial institutions. Neutral for a large company like ABT
The price-to-earnings multiple is lower than average for all stocks in the StockScouter universe. Positive
The price-to-sales multiple is about the same as the average for all stocks in the StockScouter universe. Neutral for a medium- to large-sized company like ABT
The ratio of ABT's price-to-earnings multiple to its five-year growth rate is above the average of all stocks in the StockScouter universe. Negative
The StockScouter measure of relative price change and consistency is very high. Very positive
Previous day's closing price for ABT was close to its 50-day moving average. Neutral
data provided by Verus Analytics
Learn more about the StockScouter rating system.
Page generated 5/19/2013 2:43 AM ET
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
